Lung Stent Market Size, Trends and Insights By Type (Tracheobronchial Stents, Esophageal Stents, Pulmonary Artery Stents, Lobar Bronchus Stents, Others), By Material (Metal Stents, Silicone Stents, Hybrid Stents, Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Boston Scientific Corporation
- Cook Medical Inc.
- Becton Dickinson and Company
- Medtronic plc
- Teleflex Incorporated
- Others
Reports Description
Global Lung Stent Market was valued at USD 193.9 Million in 2023 and is expected to reach USD 354.6 Million by 2032, at a CAGR of 7.4% during the forecast period 2023 – 2032.
A lung stent, also referred to as a bronchial or tracheobronchial stent, is a medical device that keeps the lungs airways open. It is primarily used in individuals with lung cancer or other obstructive lung illnesses characterized by constriction or rupture of the airways.
Lung Stent Market: Growth Factors
Rising prevalence of lung cancer
The increased frequency of lung cancer is driving the lung stent market, as there is a greater demand for therapies to control tumor-induced airway obstruction. Lung cancer frequently causes restriction or obstruction of the airways, leading to symptoms such as difficulty breathing, coughing, and wheezing.
Lung stents can help patients with advanced lung cancer relieve their symptoms and improve their quality of life. As the prevalence of lung cancer continues to climb internationally, the need for lung stents as a therapeutic option to manage airway obstruction is expected to increase, thereby driving growth in the lung stent market.
For instance, Lung cancer is the main cause of cancer mortality and incidence worldwide, with an estimated 2 million diagnoses and 1.8 million deaths. African American males in the United States have the highest risk of lung cancer. Family history raises the risk by 1.7 times, with first-degree relatives bearing the highest risk.
Tobacco smoking is the leading avoidable cause of death globally, accounting for up to 90% of lung cancer cases, and sustained use is expected to raise global cancer rates, especially in developing countries such as China, Russia, and India.
Growing demand for minimally invasive procedures
Rising demand for less invasive treatments is a prominent driver of the lung stent market, owing to the intrinsic benefits these techniques provide in treating respiratory problems.
Bronchoscopy and other minimally invasive procedures enable the placement of lung stents eliminating the need for traditional open surgery, decreasing patient discomfort, recovery time, and hospitalization.
Patients frequently choose procedures that are minimally invasive because they are less intrusive, have a lower risk of complications, and allow them to resume regular activities more quickly.
In addition, healthcare practitioners like these treatments because they are precise, safe, and cost-effective. As a result, patients with lung cancer, airway stenosis, or other obstructive lung disorders are increasingly opting for minimally invasive techniques to insert lung stents.
For instance, artificial intelligence (AI) is also revolutionizing minimally invasive techniques and plastic surgery in general. Researchers continue to see advances emerge in the plastic surgery profession, with developments accelerating as demand for minimally invasive procedures rises.
Clearstate has made improvements in minimally invasive surgery (MIS) techniques and equipment, and MIS usage is growing in a variety of surgical specialties, including orthopaedic surgery for hip and knee replacements and cardiac surgery for coronary artery bypass surgery (CABG) and valvuloplasty.
Lung Stent Market: Restraints
Alternative treatment options available
Alternative therapeutic alternatives may impede the lung stent market by providing competitive solutions for addressing airway blockage in individuals with lung cancer or other respiratory disorders.
Thus, in circumstances when surgery or chemotherapy may successfully relieve airway blockage caused by malignancies, clinicians may choose these therapies over stent implantation. Similarly, radiation treatment or bronchoscopic tumor debulking may be effective alternatives to stent implantation in some situations.
In addition, the availability of alternative treatments such as airway stenting with metallic stents, endobronchial laser therapy, and cryotherapy could restrict the need for silicone or hybrid stents in certain patient groups.
Lung Stent Market: Opportunities
Growing demand for silicone and hybrid stents
The lung stent market is being driven by increased demand for silicone and hybrid stents, which have unique features and benefits over standard metal stents. Silicone stents are flexible and conformable, making them ideal for implantation in convoluted or curved airways without causing discomfort or harm.
Additionally, silicone stents are frequently employed in individuals with benign diseases or for temporary alleviation of airway congestion. Hybrid stents, which include silicone and metal components, provide adequate assistance while reducing the risk of stent migration or tissue ingrowth. These stents are especially useful in situations when long-term airway patency is required.
For instance, according to the National Institutes of Health, silicone and metallic stents are now the most often utilized airway stents in clinical operations, providing patients with efficient therapy. Nevertheless, these permanent stents must be removed, requiring patients to undergo more invasive procedures. As a consequence, there is an increased need for biodegradable airway stents.
Lung Stent Market: Segmentation Analysis
Global Lung Stent market is segmented by type, material, end user, and region. Based on type, the market is classified into tracheobronchial stents, esophageal stents, pulmonary artery stents, lobar bronchus stents, and others.
Tracheobronchial stents dominated the market in 2022 with a market share of 35% and are expected to keep their dominance during the forecast period 2024-2032. Tracheobronchial stents boost the lung stent market by filling a vital need in airway obstruction management, especially for patients with terminal lung cancer, tracheobronchomalacia, or other disruptive respiratory diseases.
These stents are specially intended to be inserted into the trachea to help preserve airway patency, resulting in enhanced airflow and easier breathing. Tracheobronchial stents provide a less invasive alternative for controlling airway blockage, which has various advantages over standard treatment options that include surgery or radiation therapy.
They can be delivered using bronchoscopy or other minimally invasive procedures, which reduces patient discomfort, recovery time, and hospitalization. Tracheobronchial stents can also be designed to meet each patient’s anatomy and pathology, giving individualized options for optimum airway support.
Based on material, the market is classified into metal stents, silicone stents, hybrid stents and others. Metal lung stents dominated the market in 2022 with a market share of 45% and are expected to keep their dominance during the forecast period 2024-2032.
Metal lung stents dominate the lung stent market by providing a long-lasting and efficient option for controlling airway blockage in patients with diverse respiratory disorders. These stents, usually constructed of stainless steel or nitinol, give strong assistance to restricted airways, enabling better airflow and relief of respiratory symptoms.
One of the primary benefits of metal lung stents is their capacity to offer long-term structural support, making them appropriate for usage in patients with malignant airway obstruction or other disorders necessitating permanent stent insertion. Metal lung stents also have high radial strength, which helps to avoid stent collapse or migration and ensures long-term airway patency.
Based on end user, the market is classified into hospitals, ambulatory surgical centers and specialty clinics. The hospitals segment dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2032. Hospitals play an important role in boosting the lung stent market through various channels.
To begin, hospitals give primary treatment to patients suffering from respiratory disorders such as lung cancer, tracheobronchomalacia, and other obstructive lung diseases. As a result, they are at the forefront of identifying and treating airway blockages, which frequently need the insertion of lung stents to keep the airway open.
In addition, hospitals usually have specialist departments or divisions with the requisite infrastructure and experience to undertake minimally invasive operations including bronchoscopy for stent installation. This facilitates the fast and rapid implantation of lung stents in patients requiring breathing assistance.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 193.9 Million |
| Projected Market Size in 2032 | USD 354.6 Million |
| Market Size in 2022 | USD 191.5 Million |
| CAGR Growth Rate | 7.4% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Material, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Lung Stent Market: Regional Analysis
By region, Lung Stent market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Lung Stent market in 2022 with a market share of 45% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
North America has modern healthcare infrastructure and facilities, such as specialized respiratory care clinics and hospitals that are equipped with cutting-edge diagnostic and interventional technologies.
These medical centers are at the cutting edge of identifying and treating respiratory diseases, with lung stents being used as a routine therapeutic alternative for addressing airway congestion. North America has a thriving medical device business, with several suppliers and manufacturers specializing in respiratory care devices such as lung stents.
The presence of these firms, together with a favourable regulatory environment, encourages innovation and advances in lung stent technology, resulting in a generation of more effective and patient-friendly devices.
Furthermore, the increased frequency of lung cancer and other respiratory disorders in North America drives up demand for lung stents, as medical professionals work to satisfy the expanding clinical need for therapies to control airway blockage. In conclusion, these considerations position North America as a prominent player in the global lung stent market.
Lung Stent Market: Recent Developments
- In 2022, Micro-Tech Endoscopy developed the initial self-expanding tracheobronchial nitinol y-stent. The Y-shaped tracheal stent system is intended to be an adaptable compliant device to treat malignant neoplasms of the tracheobronchial carina.
- In August 2023, Theken Companies, a U.S.-based family of medical implant makers, acquired VisionAir Solutions, a spinout concentrated around technology developed at the Cleveland Clinic.
- In November 2020, AEROmini® constructed the smallest self-expanding nitinol stents In addition to through-the-scope implementation, the new AEROmini line extension includes smaller, over-the-wire stents specially developed for physicians managing patients with shorter strictures.
List of the prominent players in the Lung Stent Market:
- Boston Scientific Corporation
- Cook Medical Inc.
- Becton Dickinson and Company
- Medtronic plc
- Teleflex Incorporated
- Merit Medical Systems Inc.
- Novatech SA
- Benson Hood Laboratories Inc.
- Micro-Tech (Nanjing) Co. Ltd.
- Taewoong Medical Co. Ltd.
- Stening SRL
- EFER Endoscopy Srl
- BVM Medical Limited
- Boston Scientific Corporation
- ENDO-FLEX GmbH
- Hobbs Medical Inc.
- S&G Biotech Inc.
- Expandium S.A.
- H&H Medical Corporation
- Merit Endotek
- Others
These key players are adopting various growth strategies such as merger & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Lung Stent Market is segmented as follows:
By Type
- Tracheobronchial Stents
- Esophageal Stents
- Pulmonary Artery Stents
- Lobar Bronchus Stents
- Others
By Material
- Metal Stents
- Silicone Stents
- Hybrid Stents
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Product
- Self-Expandable Stents
- Non-Expandable Stents
By Patient
- Adult
- Pediatric
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Lung Stent Market, (2024 – 2033) (USD Million)
- 2.2 Global Lung Stent Market: snapshot
- Chapter 3. Global Lung Stent Market – Industry Analysis
- 3.1 Lung Stent Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising prevalence of lung cancer
- 3.2.2 Growing demand for minimally invasive procedures
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Material
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Lung Stent Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Lung Stent Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Lung Stent Market – Type Analysis
- 5.1 Global Lung Stent Market Overview: By Type
- 5.1.1 Global Lung Stent Market Share, By Type, 2022 and – 2033
- 5.2 Tracheobronchial Stents
- 5.2.1 Global Lung Stent Market by Tracheobronchial Stents, 2024 – 2033 (USD Million)
- 5.3 Esophageal Stents
- 5.3.1 Global Lung Stent Market by Esophageal Stents, 2024 – 2033 (USD Million)
- 5.4 Pulmonary Artery Stents
- 5.4.1 Global Lung Stent Market by Pulmonary Artery Stents, 2024 – 2033 (USD Million)
- 5.5 Lobar Bronchus Stents
- 5.5.1 Global Lung Stent Market by Lobar Bronchus Stents, 2024 – 2033 (USD Million)
- 5.6 Others
- 5.6.1 Global Lung Stent Market by Others, 2024 – 2033 (USD Million)
- 5.1 Global Lung Stent Market Overview: By Type
- Chapter 6. Global Lung Stent Market – Material Analysis
- 6.1 Global Lung Stent Market Overview: By Material
- 6.1.1 Global Lung Stent Market Share, By Material, 2022 and – 2033
- 6.2 Metal Stents
- 6.2.1 Global Lung Stent Market by Metal Stents, 2024 – 2033 (USD Million)
- 6.3 Silicone Stents
- 6.3.1 Global Lung Stent Market by Silicone Stents, 2024 – 2033 (USD Million)
- 6.4 Hybrid Stents
- 6.4.1 Global Lung Stent Market by Hybrid Stents, 2024 – 2033 (USD Million)
- 6.5 Others
- 6.5.1 Global Lung Stent Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Lung Stent Market Overview: By Material
- Chapter 7. Global Lung Stent Market – End User Analysis
- 7.1 Global Lung Stent Market Overview: By End User
- 7.1.1 Global Lung Stent Market Share, By End User, 2022 and – 2033
- 7.2 Hospitals
- 7.2.1 Global Lung Stent Market by Hospitals, 2024 – 2033 (USD Million)
- 7.3 Ambulatory Surgical Centers
- 7.3.1 Global Lung Stent Market by Ambulatory Surgical Centers, 2024 – 2033 (USD Million)
- 7.4 Specialty Clinics
- 7.4.1 Global Lung Stent Market by Specialty Clinics, 2024 – 2033 (USD Million)
- 7.1 Global Lung Stent Market Overview: By End User
- Chapter 8. Lung Stent Market – Regional Analysis
- 8.1 Global Lung Stent Market Regional Overview
- 8.2 Global Lung Stent Market Share, by Region, 2022 & – 2033 (USD Million)
- 8.3. North America
- 8.3.1 North America Lung Stent Market, 2024 – 2033 (USD Million)
- 8.3.1.1 North America Lung Stent Market, by Country, 2024 – 2033 (USD Million)
- 8.3.1 North America Lung Stent Market, 2024 – 2033 (USD Million)
- 8.4 North America Lung Stent Market, by Type, 2024 – 2033
- 8.4.1 North America Lung Stent Market, by Type, 2024 – 2033 (USD Million)
- 8.5 North America Lung Stent Market, by Material, 2024 – 2033
- 8.5.1 North America Lung Stent Market, by Material, 2024 – 2033 (USD Million)
- 8.6 North America Lung Stent Market, by End User, 2024 – 2033
- 8.6.1 North America Lung Stent Market, by End User, 2024 – 2033 (USD Million)
- 8.7. Europe
- 8.7.1 Europe Lung Stent Market, 2024 – 2033 (USD Million)
- 8.7.1.1 Europe Lung Stent Market, by Country, 2024 – 2033 (USD Million)
- 8.7.1 Europe Lung Stent Market, 2024 – 2033 (USD Million)
- 8.8 Europe Lung Stent Market, by Type, 2024 – 2033
- 8.8.1 Europe Lung Stent Market, by Type, 2024 – 2033 (USD Million)
- 8.9 Europe Lung Stent Market, by Material, 2024 – 2033
- 8.9.1 Europe Lung Stent Market, by Material, 2024 – 2033 (USD Million)
- 8.10 Europe Lung Stent Market, by End User, 2024 – 2033
- 8.10.1 Europe Lung Stent Market, by End User, 2024 – 2033 (USD Million)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Lung Stent Market, 2024 – 2033 (USD Million)
- 8.11.1.1 Asia Pacific Lung Stent Market, by Country, 2024 – 2033 (USD Million)
- 8.11.1 Asia Pacific Lung Stent Market, 2024 – 2033 (USD Million)
- 8.12 Asia Pacific Lung Stent Market, by Type, 2024 – 2033
- 8.12.1 Asia Pacific Lung Stent Market, by Type, 2024 – 2033 (USD Million)
- 8.13 Asia Pacific Lung Stent Market, by Material, 2024 – 2033
- 8.13.1 Asia Pacific Lung Stent Market, by Material, 2024 – 2033 (USD Million)
- 8.14 Asia Pacific Lung Stent Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Lung Stent Market, by End User, 2024 – 2033 (USD Million)
- 8.15. Latin America
- 8.15.1 Latin America Lung Stent Market, 2024 – 2033 (USD Million)
- 8.15.1.1 Latin America Lung Stent Market, by Country, 2024 – 2033 (USD Million)
- 8.15.1 Latin America Lung Stent Market, 2024 – 2033 (USD Million)
- 8.16 Latin America Lung Stent Market, by Type, 2024 – 2033
- 8.16.1 Latin America Lung Stent Market, by Type, 2024 – 2033 (USD Million)
- 8.17 Latin America Lung Stent Market, by Material, 2024 – 2033
- 8.17.1 Latin America Lung Stent Market, by Material, 2024 – 2033 (USD Million)
- 8.18 Latin America Lung Stent Market, by End User, 2024 – 2033
- 8.18.1 Latin America Lung Stent Market, by End User, 2024 – 2033 (USD Million)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Lung Stent Market, 2024 – 2033 (USD Million)
- 8.19.1.1 The Middle-East and Africa Lung Stent Market, by Country, 2024 – 2033 (USD Million)
- 8.19.1 The Middle-East and Africa Lung Stent Market, 2024 – 2033 (USD Million)
- 8.20 The Middle-East and Africa Lung Stent Market, by Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Lung Stent Market, by Type, 2024 – 2033 (USD Million)
- 8.21 The Middle-East and Africa Lung Stent Market, by Material, 2024 – 2033
- 8.21.1 The Middle-East and Africa Lung Stent Market, by Material, 2024 – 2033 (USD Million)
- 8.22 The Middle-East and Africa Lung Stent Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Lung Stent Market, by End User, 2024 – 2033 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Boston Scientific Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Cook Medical Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Becton Dickinson and Company
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Medtronic plc
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Teleflex Incorporated
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Merit Medical Systems Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Novatech SA
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 E. Benson Hood Laboratories Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Micro-Tech (Nanjing) Co. Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Taewoong Medical Co. Ltd.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Stening SRL
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 EFER Endoscopy Srl
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 BVM Medical Limited
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Boston Scientific Corporation
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 ENDO-FLEX GmbH
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Hobbs Medical Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 S&G Biotech Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Expandium S.A.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 H&H Medical Corporation
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Merit Endotek
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Boston Scientific Corporation
List Of Figures
Figures No 1 to 28
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Boston Scientific Corporation
- Cook Medical Inc.
- Becton Dickinson and Company
- Medtronic plc
- Teleflex Incorporated
- Merit Medical Systems Inc.
- Novatech SA
- Benson Hood Laboratories Inc.
- Micro-Tech (Nanjing) Co. Ltd.
- Taewoong Medical Co. Ltd.
- Stening SRL
- EFER Endoscopy Srl
- BVM Medical Limited
- Boston Scientific Corporation
- ENDO-FLEX GmbH
- Hobbs Medical Inc.
- S&G Biotech Inc.
- Expandium S.A.
- H&H Medical Corporation
- Merit Endotek
- Others
FAQs
The restraints of the Lung Stent market is alternative treatment options available.
The major driver for the Lung Stent market is rising prevalence of lung cancer and growing demand for minimally invasive procedures.
The “Tracheobronchial Stents” category dominated the market in 2022.
The key players in the market are Boston Scientific Corporation, Cook Medical Inc., Becton Dickinson and Company, Medtronic plc, Teleflex Incorporated, Merit Medical Systems Inc., Novatech SA, E. Benson Hood Laboratories Inc., Micro-Tech (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Stening SRL, EFER Endoscopy Srl, BVM Medical Limited, Boston Scientific Corporation, ENDO-FLEX GmbH, Hobbs Medical Inc., S&G Biotech Inc., Expandium S.A., H&H Medical Corporation, Merit Endotek, Others.
“North America” had the largest share in the Lung Stent Market.
The global market is projected to grow at a CAGR of 7.4% during the forecast period, 2023-2032.
The Lung Stent Market size was valued at USD 193.9 Million in 2023.